|
Volumn 410, Issue 6832, 2001, Pages 1046-1047
|
Analysis of oral polio vaccine CHAT stocks
a a a b b c d a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MITOCHONDRIAL DNA;
POLIOMYELITIS VACCINE;
VIRUS RNA;
ORAL POLIOMYELITIS VACCINE;
VIRUS DNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CHIMPANZEE;
DRUG CONTAMINATION;
DRUG FORMULATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MONKEY DISEASE;
NONHUMAN;
POLIOMYELITIS VIRUS;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
VIRUS TRANSMISSION;
ANIMAL;
GENETICS;
HUMAN;
ISOLATION AND PURIFICATION;
MACACA;
PAN TROGLODYTES;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SAFETY;
SIMIAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
PAN TROGLODYTES;
POLIOVIRUS;
RNA VIRUSES;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANIMALS;
CONSUMER PRODUCT SAFETY;
DNA, VIRAL;
DRUG CONTAMINATION;
HIV-1;
HUMANS;
MACACA;
PAN TROGLODYTES;
POLIOVIRUS VACCINE, ORAL;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SIMIAN IMMUNODEFICIENCY VIRUS;
|
EID: 0035953640
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/35074176 Document Type: Article |
Times cited : (30)
|
References (7)
|